Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search
Fullscreen

For citations:


Kurenkov A.L., Kuzenkova L.M., Bursagova B.I., Chernikov V.V., Agranovich O.V., Khachatryan L.G., Kenis V.M., Zherebtsova V.A., Sarzhina M.N., Odinaeva N.D., Artemenko A.R., Popova G.A., Moroshek E.A., Tabe E.E., Nezhelskaya A.A., Maksimenko A.A., Akhadova L.Y., Indereikin M.V., Duibanova N.V., Tikhonova L.V., Sapogovskiy A.V., Gadzhialieva Z.M., Grigorieva A.V., Perminov V.S., Fedonyuk I.D., Kolpakchi L.M., Kursakova A.Yu., Tsurina N.A. Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(2):117-125. https://doi.org/10.14412/2074-2711-2022-2-117-125

Views: 15


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)